All terms in COVID

Label Id Description
dabrafenib CHEBI_75045 [An organofluorine compound and antineoplastic agent, used as its mesylate salt in treatment of metastatic melanoma.]
rare pulmonary disease MONDO_0015118 [Rare lung diseases may involve the lung only or multiple organs and those which are not widely researched, where specific treatment is not available, and which may only be of limited interest to scientists and doctors.]
autoimmune disease OBI_1110054 [Is a disease characterized by an immune response of an organism against parts of itself]
SARS coronavirus TWY NCBITaxon_240553
Presatovir NCIT_C118505 [An orally available inhibitor of human respiratory syncytial virus (RSV) fusion protein (F protein), with potential antiviral activity. Upon oral administration of GS-5806, this agent specifically binds to F protein on the viral surface, which inhibits RSV F protein-mediated fusion with the host cell membrane and prevents viral entry. This blocks RSV replication, reduces viral load, and decreases the severity of the disease. RSV F protein, a viral surface glycoprotein, plays a key role in RSV fusion with and entry into target cells.]
viral gene expression GO_0019080 [A process by which a viral gene is converted into a mature gene product or products (proteins or RNA). This includes viral transcription, processing to produce a mature RNA product, and viral translation.]
SARS coronavirus TWK NCBITaxon_240551
viral translation GO_0019081 [A process by which viral mRNA is translated into viral protein, using the host cellular machinery.]
FASLG OGG_3000000356
SARS coronavirus TWS NCBITaxon_240552
viral protein processing GO_0019082 [Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a viral protein.]
viral transcription GO_0019083 [The process by which a viral genome, or part of a viral genome, is transcribed within the host cell.]
SARS coronavirus TWJ NCBITaxon_240550
FYN OGG_3000002534
Cytokine Release Syndrome NCIT_C78251 [A syndrome that occurs after therapeutic infusion of antibodies into the blood and is characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath. It is caused by the release of cytokines from the cells that are targeted by the antibodies. Most patients experience a mild to moderate reaction; however, the reaction may be severe and life-threatening.]
viral release from host cell GO_0019076 [The dissemination of mature viral particles from the host cell, e.g. by cell lysis or the budding of virus particles from the cell membrane.]
viral genome replication GO_0019079 [Any process involved directly in viral genome replication, including viral nucleotide metabolism.]
HAVCR2 OGG_3000084868
Human adenovirus 2 NCBITaxon_10515
SARS coronavirus GD03T0013 NCBITaxon_262338